APYX
Apyx Medical Corporation
$2.02
-$0.27(-11.79%)
50
Overall
--
Value
50
Tech
--
Quality
Market Cap
$86.61M
Volume
59.92K
52W Range
$0.76 - $2.73
Target Price
$4.00
Order:
Income Statement
| Metric | Trend | Chart | 2014 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $27.7M | $36.6M | $10.2M | $16.6M | $28.2M | $27.7M | $48.5M | $44.5M | $52.3M | $48.1M | ||
| Total Revenue | $27.7M | $36.6M | $10.2M | $16.6M | $28.2M | $27.7M | $48.5M | $44.5M | $52.3M | $48.1M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $18.7M | $18.7M | $3.3M | $-5.8M | $9.1M | $10.2M | $14.9M | $15.4M | $18.6M | $18.7M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $9.0M | $17.9M | $7.0M | $10.8M | $19.1M | $17.5M | $33.6M | $29.1M | $33.8M | $29.4M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $14.8M | $21.7M | $19.3M | $-25.1M | $40.3M | $37.6M | $48.0M | $52.7M | $53.7M | $48.2M | ||
| Research & Development | $1.4M | $2.6M | $1.9M | $2.5M | $3.7M | $3.9M | $4.3M | $4.5M | $5.4M | $5.1M | ||
| Research Expense | $1.4M | $2.6M | $1.9M | $2.5M | $3.7M | $3.9M | $4.3M | $4.5M | $5.4M | $5.1M | ||
| Selling, General & Administrative | $7.7M | $10.1M | $10.5M | $12.5M | $22.2M | $19.0M | $26.2M | $29.5M | $29.2M | $25.8M | ||
| Selling & Marketing Expenses | -- | $-700.0K | $-600.0K | $9.4M | $13.7M | $800.0K | $1.3M | $2.3M | $8.3M | $5.8M | ||
| General & Administrative Expenses | $7.7M | $10.1M | $10.5M | $3.1M | $8.5M | $19.0M | $26.2M | $29.5M | $29.2M | $25.8M | ||
| Promotion & Advertising | -- | $-700.0K | $-600.0K | $-800.0K | $-1.5M | $800.0K | $1.3M | $2.3M | $1.8M | $1.3M | ||
| Salaries & Wages | $5.7M | $9.0M | $6.9M | $9.3M | $14.0M | $14.6M | $17.5M | $18.6M | $19.0M | $17.4M | ||
| Depreciation & Amortization | -- | $-734.0K | $-600.0K | $-400.0K | $-700.0K | $700.0K | $700.0K | $700.0K | $700.0K | $600.0K | ||
| Depreciation & Amortization | -- | $-734.0K | $-600.0K | $-400.0K | $-700.0K | $700.0K | $700.0K | $700.0K | $700.0K | $600.0K | ||
| Amortization | $-108.0K | $-100.0K | $-100.0K | $-100.0K | $-57.0K | $216.0K | $216.0K | $138.0K | $31.0K | $21.0K | ||
| Other Operating Expenses | -- | -- | -- | $947.0K | $351.0K | $-479.0K | $373.0K | $-509.0K | $-2.7M | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-5.8M | $-3.8M | $-12.4M | $-14.4M | $-21.2M | $-20.1M | $-14.4M | $-23.6M | $-17.3M | $-18.8M | ||
| EBITDA | $-12.3M | $-3.0M | $-13.0M | $-13.9M | $-19.1M | $-18.5M | $-13.9M | $-22.0M | $-20.6M | $-22.7M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $151.0K | $158.0K | $136.0K | $104.0K | $8.0K | $46.0K | $10.0K | $15.0K | $2.0K | $1.0K | ||
| Interest Income Operating | -- | -- | -- | $616.0K | $1.4M | $241.0K | $11.0K | $157.0K | $921.0K | -- | ||
| Intinc | -- | -- | -- | -- | -- | -- | -- | -- | $921.0K | $1.6M | ||
| Net Non-Operating Interest Income/Expense | $-151.0K | $-158.0K | $-136.0K | $-104.0K | $-8.0K | $-46.0K | $-10.0K | $-142.0K | $921.0K | $1.6M | ||
| Gain on Sale of Securities | $-7.3M | $64.0K | $183.0K | $20.0K | -- | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $7.3M | $-64.0K | $-183.0K | $-20.0K | $-1.0M | -- | -- | $509.0K | $2.5M | $161.0K | ||
| Other Special Charges | $10.5M | -- | -- | $-415.0K | $1.0M | -- | -- | $200.0K | $-2.5M | $-161.0K | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | $1.5M | $741.0K | -- | -- | -- | -- | -- | -- | ||
| Special Income Charges | -- | -- | $-1.5M | $-741.0K | -- | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-13.1M | $-3.7M | $-13.7M | $-14.6M | $-19.8M | $-19.4M | $-14.8M | $-22.9M | $-21.3M | $-23.3M | ||
| Pre-Tax Income | $-13.3M | $-3.9M | $-13.8M | $-14.7M | $-19.8M | $-19.4M | $-14.8M | $-22.9M | $-21.3M | $-23.3M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $4.0M | $64.0K | $-156.0K | $-3.9M | $-130.0K | $-7.5M | $380.0K | $367.0K | $-2.4M | $252.0K | ||
| NET INCOME | ||||||||||||
| Net Income | $-17.3M | $-4.0M | $-13.7M | $57.7M | $-19.7M | $-11.9M | $-15.2M | $-23.2M | $-18.7M | $-23.5M | ||
| Net Income (Continuing Operations) | $-17.3M | $-4.0M | $-13.7M | $57.7M | $-19.7M | $-11.9M | $-15.2M | $-23.3M | $-18.9M | $-23.6M | ||
| Net Income (Discontinued Operations) | $-17.3M | $-4.0M | $-13.7M | $57.7M | $-19.7M | $-11.9M | $-15.2M | $-23.2M | $-18.7M | $-23.5M | ||
| Net Income (Common Stockholders) | $-18.2M | $-4.0M | $-13.7M | $57.7M | $-19.7M | $-11.9M | $-15.2M | $-23.2M | $-18.7M | $-23.5M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-23.1M | ||
| TOTALS | ||||||||||||
| Total Expenses | $33.5M | $40.4M | $22.6M | $-30.9M | $49.5M | $47.8M | $63.0M | $68.1M | $72.3M | $66.9M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $17.8M | $27.4M | $31.4M | $33.2M | $34.1M | $34.2M | $34.3M | $34.5M | $34.6M | $35.5M | ||
| Average Shares Outstanding (Diluted) | $17.8M | $27.4M | $31.4M | $34.4M | $34.1M | -- | $34.3M | $34.5M | $34.6M | $35.5M | ||
| Shares Outstanding | $18.0M | $30.9M | $33.0M | $34.0M | $34.2M | $34.3M | $34.4M | $34.6M | $34.6M | $37.8M | ||
| Basic EPS | $-1.03 | $-0.14 | $-0.50 | $1.89 | $-0.58 | $-0.35 | $-0.44 | $-0.67 | $-0.54 | $-0.66 | ||
| Basic EPS (Continuing Operations) | $-1.03 | $-0.14 | $-0.77 | -- | $-0.58 | $-0.35 | $-0.44 | $-0.67 | $-0.54 | $-0.66 | ||
| Diluted EPS | $-1.03 | $-0.15 | $0.27 | $1.83 | $-0.58 | $-0.35 | $-0.44 | $-0.67 | $-0.54 | $-0.66 | ||
| Diluted EPS (Continuing Operations) | $-1.03 | $-0.15 | $-0.17 | -- | $-0.58 | -- | $-0.44 | $-0.67 | $-0.54 | -- | ||
| OTHER METRICS | ||||||||||||
| Accrued Preferred Stock Dividends | $932.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Basic Discontinuous Operations | -- | -- | $0.27 | $2.21 | -- | -- | -- | -- | -- | -- | ||
| Commission Expenses | -- | -- | -- | -- | -- | -- | -- | -- | $6.5M | $4.5M | ||
| Diluted Discontinuous Operations | -- | -- | $0.27 | $2.14 | -- | -- | -- | -- | -- | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | -- | -- | -- | $68.4M | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | -- | -- | -- | -- | -- | $10.0K | $28.0K | $94.0K | $137.0K | $96.0K | ||
| Net Income Discontinuous Operations | -- | -- | -- | $68.4M | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $7.7M | $10.1M | $10.5M | $3.1M | $8.5M | $19.0M | $26.2M | $29.5M | $29.2M | $25.8M | ||
| Otherunder Preferred Stock Dividend | $932.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $932.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $-72.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | -- | -- | -- | $9.4M | $13.7M | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | $1.5M | $741.0K | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APYX | $2.02 | -11.8% | 59.92K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Apyx Medical Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW